vimarsana.com

Computing Infrastructure News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Matrix IT : Immidiate Report -April 09, 2024 at 11:43 am EDT

Pneumonitis Risk in NSCLC Remains Uncertain, Obesity May Be Predictor

Outcomes were evaluated among veterans treated for non–small cell lung cancer (NSCLC) from 2017 to 2020 with durvalumab, a PD-L1 inhibitor.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.